Literature DB >> 34850616

Comparative study of human growth hormone measurements: impact on clinical interpretation.

Manuela Lotierzo1,2, Florin Olaru-Soare1, Anne-Marie Dupuy1, Maëlle Plawecki1,2, Françoise Paris1,3, Jean-Paul Cristol1,2.   

Abstract

OBJECTIVES: Human growth hormone (hGH) provocation test is an essential tool to assess growth hormone deficiency (GHD) in children and young adults. It is important to have a robust method to determine the hGH peak of stimulation. This work aimed to compare three common automated immunoassays for hGH quantification and to ascertain whether there are still result-related differences which can impact clinical decision.
METHODS: We analyzed the GH provocation test for 39 young subjects from pediatric department of Montpellier hospital, admitted for suspicion of growth hormone deficiency. The full range of measurements as well as the peak level of serum GH were compared using three automated immunoassays on three different immunoanalyzers: IDS-hGH on iSYS, LIAISON-hGH on Liaison XL and Elecsys ROCHE-hGH, on COBAS 8000.
RESULTS: A good correlation was obtained between methods for all measurements (r 2>0.99) by using Passing-Bablok regression analysis. Bland-Altman analysis showed the best agreement between IDS-hGH and LIAISON-hGH systems (bias=-14.5%) compared to Elecsys ROCHE-hGH (bias=28.3%). When considering stratification of the study population and a unique cutoff, there were some discrepancies in interpretation of the results especially concerning the more recent Elecsys ROCHE-hGH assay. Nevertheless, when the adequate cutoff for each method was taken into account results were well correlated for all systems.
CONCLUSIONS: A cutoff for Elecsys Roche-hGH method was established to better explain the results. Clinician must be aware of the use of assay-specific cutoff to correctly integrate the results of GH tests in the GHD diagnosis.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  cutoff; growth hormone deficiency; human growth hormone (hGH) provocation test; immunoanalysis

Mesh:

Substances:

Year:  2021        PMID: 34850616     DOI: 10.1515/cclm-2021-1109

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  1 in total

Review 1.  Growth Hormone Stimulation Testing: To Test or Not to Test? That Is One of the Questions.

Authors:  Mabel Yau; Robert Rapaport
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.